May 25, 2007 by Billy FisherStretched to the Limit at LimitedThe retailer cuts its full-year outlook upon experiencing lower-than-anticipated Q1 sales.
May 23, 2007 by Billy FisherA Lackluster Quarter for the Diamond StoreSlowing revenues at Zale leads the retailer to predict red for the year.
May 14, 2007 by Billy FisherSears, Sun-Times Square OffA Chicago columnist blasts Sears' new ads, and the managers behind them.
May 9, 2007 by Billy FisherA Growing Bandwagon at VIASYSThe medical device maker has been expanding globally.
May 8, 2007 by Billy FisherWellCare Bucks the ExpertsThe managed-care company reports a strong quarter after several downgrades.
May 4, 2007 by Billy FisherIn Search of New Prey at FoxHollowThe medical device maker reported a 6% increase in revenues on a year-over-year basis for its Q1.
May 4, 2007 by Billy FisherDefying Expectations at MolinaThe managed care company does not fall victim to slowing economy in its first quarter.
Apr 25, 2007 by Billy FisherA Healthy Diet of Profits at WellPointFor the nation's largest health insurer, the waters aren't always going to be smooth for sailing.
Apr 25, 2007 by Billy FisherReynolds American Lights Up AgainThe tobacco company's first quarter doesn't go up in smoke.
Apr 23, 2007 by Billy FisherStudent Loan Corp. in the SpotlightSLC is doing fairly well in a thriving industry. But that doesn't mean there are no risks.
Apr 23, 2007 by Billy FisherRobust Returns in RoboticsIntuitive Surgical's da Vinci robot arms reel in profits.
Apr 20, 2007 by Billy FisherFeverish Growth at Meridian BioscienceThe maker of diagnostic test kits is heating up.
Apr 20, 2007 by Billy FisherA Kraft-Free Life for AltriaDuring the quarter, Altria got rid of its dead weight.
Apr 20, 2007 by Billy FisherMany Ways to Feel Good About WyethThe drugmaker's pipeline makes investors look forward to the next few quarters, too.
Apr 19, 2007 by Billy FisherA Saintly QuarterShares of St. Jude Medical rise after the company announces a big quarter.
Apr 11, 2007 by Billy FisherA Replacement for Vioxx at Merck?Drug company has new pain medication in the pipeline.
Apr 5, 2007 by Billy FisherAnother Boost for ImmucorThe company wields pricing power, which is helping margins.